Reuters - Groups Dismayed by Decision Not to Cover Alzheimer's Test - Julie Steenhuysen

New York, NY
 – July 9, 2013  –– 

Alzheimer's experts are set to protest after Medicare issued draft guidelines last week saying it would only pay for an Eli Lilly and Co. diagnostic test for the disease if patients were taking part in clinical trials. Both Lilly and the Alzheimer's Association have released statements expressing disappointment with the decision by the United States Centers for Medicare and Medicaid Services (CMS), which cited "insufficient" evidence that the tests improve patient care. "I think CMS found a way to do something truly constructive while holding back what will undoubtedly be a tsunami of worried well who, if they had access to amyloid scans, would find that they have amyloid in their brains that is largely asymptomatic," said Sam Gandy, MD, Associate Director of the Alzheimer's Disease Research Center at the Icahn School of Medicine at Mount Sinai.
-Dr. Sam Gandy, Professor, Neurology, Psychiatry, Associate Director of the Mount Sinai Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai 
Learn more